Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Methylation of human papillomavirus-52 and -58 is a candidate biomarker in cervical neoplasia.

Methylation of human papillomavirus-52 and -58 is a candidate biomarker in cervical neoplasia. J Clin Virol. 2013 Sep; 58(1):149-54.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.